stockrow
Friday 6 November 2026
Export SNGX’s income statement to Excel — free account
Soligenix Inc.
SNGX Healthcare Biotechnology
Soligenix Inc.’s revenue for fiscal 2024 (year ended December 2024) was $119,400.00, down 85.8% from fiscal 2023.
- EPS
- +85.4%
- Free cash flow
- +37.8%
Quarter to June 2026, against a year earlier
0.34
0.01
+3.03%
Follow SNGX
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.08 | 2.15 | 1.67 | 2.67 | |
Current Ratio |
3.18 | 2.39 | 1.81 | 2.77 | |
Net Debt/EBITDA |
4.08 | 2.28 | 2.09 | 4.68 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.16 | 0.95 | 0.83 | 0.86 | |
Capex/Depreciation |
(0.67) | (2.00) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.68) | (0.53) | (0.23) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.68) | (0.53) | (0.23) | (0.11) | |
Cash per Share |
2.43 | 1.53 | 0.59 | 0.62 | |
Shareholders Equity per Share |
1.75 | 1.02 | 0.30 | 0.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.75 | 1.02 | 0.30 | 0.42 | |
Free Cash Flow |
(2.93) | (2.75) | (2.36) | (1.71) | |
Working Capital |
7.46 | 5.15 | 2.95 | 6.50 | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
7.19 | 4.91 | 2.73 | 6.32 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
1.05 | 0.89 | 0.71 | 1.03 | |
Average Assets |
10.89 | 9.10 | 7.33 | 8.13 | |
Average Common Equity |
6.77 | 4.71 | 3.35 | 4.24 |
Columns are period end dates · fundamentals updated 26 Oct 2026